Found Weight Loss Review 2026

Found Weight Loss Review 2026: Holistic GLP-1 Program with Coaching

Medically reviewed by Telehealth Ally Medical Review Team. Pricing and protocol data last verified April 2026.

April 2026 context: Found is transitioning from compounded GLP-1 medications toward branded alternatives as FDA enforcement accelerates. Orforglipron (PDUFA April 10, 2026) is expected to become the primary budget pathway if approved. Medicare GLP-1 Bridge pending.

Found takes a different approach than most GLP-1 telehealth providers. Instead of purely prescribing medication, Found combines GLP-1 medications with behavior change coaching, nutrition guidance, and community support. Their thesis: medication alone isn't enough for sustainable weight loss.

That thesis is particularly relevant in April 2026. With compounded semaglutide under FDA enforcement pressure and branded GLP-1 prices still significant, patients need strategies to maximize results and manage the eventual transition off medication. Found's coaching model addresses this directly.

What's changed heading into 2026?

• Compounded semaglutide is gone. Like all telehealth providers, Found lost access to compounded GLP-1 medications as FDA enforcement eliminated the compounding market through 2026.
• Orforglipron as the expected budget anchor. If orforglipron receives FDA approval on April 10, 2026, it would be the primary affordable branded option at $149/month (plus Found's program fee) — with no compounding risk.
• Medicare Bridge access. Medicare GLP-1 Bridge coverage for obesity medications is pending Congressional action; not yet available.
• Coaching model validated. With weight regain concerns growing (STEP 1 extension: 67% regain after stopping), Found's behavioral approach has become a stronger selling point.

How does Found's program work?

Found combines board-certified obesity medicine physicians with ongoing behavioral coaching — a model that differs from both budget prescription-only services and premium clinical programs like Calibrate. Video consultations are included, unlike Ro and Hims.

1. Comprehensive intake — Medical questionnaire that goes beyond basic BMI screening. Found asks about eating patterns, sleep, stress levels, physical activity, and weight loss history.
2. Board-certified provider match — You're matched with a physician who specializes in obesity medicine. Found offers both async messaging and video consultations — a differentiator from Ro and Hims.
3. Personalized treatment plan — Your provider creates a plan combining GLP-1 medication with specific behavioral goals.
4. Ongoing coaching — Regular check-ins with your care team, community support forums, and educational content on nutrition and lifestyle changes.
5. Medication shipped — Branded medication delivered to your door.

Pricing last verified April 2026. We update pricing data monthly. Contact us if you spot an error.

How much does Found cost per month?

Found's all-in cost depends on which medication you use. The program fee is charged on top of medication costs, making Found more expensive than Ro for medication-only access — but the price includes coaching and video consultations that Ro doesn't offer.

Medication	Monthly Cost	Route	Notes
Orforglipron	$149/mo + program fee	Oral pill	Budget option. No fasting required.
Oral Wegovy (semaglutide)	$199-299/mo + program fee	Oral pill	Higher efficacy. 30-min fasting window.
Wegovy (semaglutide 2.4mg)	Insurance-dependent	Weekly injection	Requires insurance + PA.
Wegovy HD (semaglutide 7.2mg)	Insurance-dependent	Weekly injection	20.7% mean weight loss.
Zepbound (tirzepatide)	$299/mo + program fee	Weekly injection	Dual GIP/GLP-1 agonist.
Medicare patients	~$50/mo copay	Varies	Medicare Bridge Program. Requires PA.

Found's pricing includes the program fee on top of medication cost. The all-in cost is higher than Ro (which charges no subscription fee), but includes coaching, video consultations, and behavioral support that Ro doesn't offer.

What makes Found different from other GLP-1 programs?

Found's key differentiator is their emphasis on behavior change alongside medication. This matters more in 2026 than ever — and it's what separates Found from both budget providers like Henry Meds and premium clinical programs like Calibrate:

• Weight regain is the central challenge. The STEP 1 extension trial showed participants regained ~67% of lost weight within 1 year of discontinuing semaglutide (Wilding et al., Diabetes Obes Metab 2022). Building sustainable habits while on medication is the best available hedge against regain.
• Obesity is multifactorial. Sleep, stress, and eating behaviors all contribute to weight. Addressing these factors alongside medication may improve both short-term results and long-term maintenance.
• Board-certified obesity medicine specialists understand the complex biology of weight regulation better than general practitioners.
• Post-compounding landscape favors behavior change. With compounded GLP-1 supply declining under FDA enforcement, patients paying branded prices have even more incentive to build habits that reduce reliance on long-term medication.

That said, the quality of coaching varies by provider, and Found's coaching is not equivalent to the intensive behavioral therapy studied in clinical trials.

What medications does Found offer?

• Orforglipron — Oral daily pill, $149/mo (announced). Awaiting FDA approval (PDUFA April 10, 2026). ACHIEVE-1: 12.4% mean weight loss. 59% nausea rate (mostly early weeks).
• Oral Wegovy (semaglutide) — Oral daily pill, $199-299/mo. 15.1% mean weight loss. Requires 30-minute fasting window.
• Wegovy (semaglutide 2.4mg) — Weekly injection. Insurance-dependent. STEP 1: 14.9% mean weight loss.
• Wegovy HD (semaglutide 7.2mg) — Weekly injection. Insurance-dependent. STEP UP: 20.7% mean weight loss. Dysesthesia risk (18.9%).
• Zepbound (tirzepatide) — Weekly injection. $299/mo or insurance. SURMOUNT-1: 22.5% mean weight loss.

Found does not currently offer non-GLP-1 weight loss medications (e.g., bupropion/naltrexone).

Clinical Protocol

Found combines board-certified obesity medicine physicians with behavioral coaching. Initial intake requires a video consultation — a differentiator from Ro, Hims, and Henry Meds, which are async-only.

What doses does Found start patients on?

Titration schedules follow FDA-approved protocols for each medication:

• Orforglipron: Daily oral pill; no fasting required. The ACHIEVE-1 starting dose was 12 mg/day. Found has not yet published a finalized titration protocol — titration details will be confirmed as the program rolls out. FDA approval pending (PDUFA date: April 10, 2026); confirm availability with Found directly.
• Wegovy injectable (semaglutide): 0.25 mg/week × 4 weeks → 0.5 mg/week × 4 weeks → 1.0 mg/week × 4 weeks → 1.7 mg/week × 4 weeks → 2.4 mg/week maintenance (insurance-dependent)
• Zepbound (tirzepatide): 2.5 mg/week × 4 weeks → 5 mg/week → 7.5 mg → 10 mg → 12.5 mg → 15 mg/week maintenance ($299/mo cash-pay or insurance)

What medications does Found currently prescribe?

• Orforglipron (oral GLP-1 agonist, $149/mo cash-pay) — Pending FDA approval as of April 2026; daily oral tablet, no refrigeration or fasting window required
• Brand Wegovy (semaglutide injectable) — Available via insurance; Found handles prior authorization
• Brand Zepbound (tirzepatide) — $299/mo cash-pay or insurance
• Brand oral Wegovy ($199–$299/mo) — FDA-approved oral semaglutide
• Found maintains a broader formulary including non-GLP-1 weight management medications for patients unable to access GLP-1s

Does Found require lab work before prescribing?

No labs are required as a standard part of enrollment. Found's board-certified obesity medicine physicians may recommend labs during the intake video consultation based on individual clinical assessment — this is physician discretion, not a program requirement. Patients with metabolic comorbidities or cardiovascular risk factors should discuss baseline testing with their provider.

Who prescribes at Found, and how does the consultation work?

Found's prescribers are board-certified obesity medicine physicians (MD/DO). The consultation model begins with a required video intake visit — typically 30–45 minutes — followed by async messaging for ongoing care. Ro, Hims, and Henry Meds default to async intake — Found does not.

How often does Found check in with patients?

Found includes behavioral coaching check-ins alongside async provider messaging. The specific coaching cadence is not publicly documented. Dose adjustment decisions are made through provider messaging, with video visits available at clinical milestones.

How does Found manage side effects?

Provider messaging is available for side effect questions. Found's behavioral coaching addresses lifestyle factors — meal timing, portion size, fat content — that directly affect GI tolerance of GLP-1 medications. No specific antiemetic protocol is publicly documented. Dose holds or reductions are accessible via provider messaging.

What are the pros of Found?

• Holistic care model — Medication combined with coaching, nutrition guidance, and community support
• Video consultations available — Unlike Ro and Hims, Found offers face-to-face virtual visits with your physician
• Board-certified obesity medicine physicians — Specialists, not just general practitioners
• Weight regain prevention focus — Behavioral coaching addresses the biggest long-term challenge with GLP-1 treatment
• Full branded medication lineup — Orforglipron through Zepbound, covering every price point and route
• Medicare Bridge support — Helps Medicare patients access GLP-1 at ~$50/mo copay

What are the cons of Found?

• Higher total cost than Ro — Program fee on top of medication means you'll pay more all-in than Ro's $149/mo flat rate
• Slower shipping — 5-7 business days is longer than most competitors (3-5 days)
• No lab testing — Blood work not included. Calibrate includes comprehensive lab panels.
• Coaching quality varies — Not all coaches are equally experienced; some patients report inconsistent engagement
• Limited medication options — GLP-1 only; no other weight management drugs

Who is Found best for?

• Patients who want more than just a prescription — The coaching and behavior change component adds real value for patients willing to engage
• People with a history of weight cycling who want support building sustainable habits to reduce regain risk
• Patients who prefer video consultations with their physician
• Those seeking obesity medicine specialists rather than general telehealth providers
• Patients planning eventual GLP-1 discontinuation — Found's behavioral framework is designed to sustain results after stopping medication

Who should look elsewhere?

• Patients who just want affordable medication — Ro offers branded GLP-1 at $149/mo with no program fee. If you're looking for the cheapest way to get semaglutide online, Found is not the right fit.
• Those wanting comprehensive lab work — Calibrate includes metabolic blood panels
• Patients needing urgent medication access — Found's 5-7 day shipping is slower than competitors
• Fully self-directed patients who don't want coaching check-ins

Is Found worth it?

Found occupies a smart niche in the post-compounding GLP-1 market: clinical medication access with meaningful behavioral support at a mid-tier price. The coaching model — which felt like a "nice to have" when compounded semaglutide was $149/mo — matters more as enforcement pressure reduces compounding access and branded options cost more.

The all-in cost is higher than Ro, and the coaching quality isn't uniformly excellent. But for patients who will actively engage with the behavioral component — particularly those with a history of weight cycling or those concerned about life after GLP-1 — Found offers the best balance of clinical care, support, and value in its category.

Rating: 4.2/5 (April 2026 — Found's coaching model is well-differentiated as the compounded market contracts, but pricing and shipping remain drawbacks)

Frequently Asked Questions

Is Found (joinfound.com) legit? Yes. Found is a legitimate telehealth weight loss provider staffed by board-certified obesity medicine physicians. They offer video consultations, behavioral coaching, and a full lineup of branded GLP-1 medications. They are not a prescription mill — the intake process includes behavioral and lifestyle assessment alongside medical screening.

How much does Found cost without insurance? Found's cost depends on medication. Orforglipron (pending approval) would be $149/month plus Found's program fee. Oral Wegovy runs $199-299/month plus program fee. Zepbound is $299/month plus program fee. With insurance covering injectable medications, you pay a copay plus Found's program fee.

Does Found take insurance? Found accepts insurance for injectable GLP-1 medications (Wegovy, Zepbound) and handles prior authorizations. The program fee itself is a separate cash-pay charge. Medicare patients can access GLP-1 at approximately $50/month copay through the Medicare Bridge Program with Found's support.

How do I cancel Found? Contact Found's patient support team to cancel your subscription. Found typically operates on a month-to-month basis after any initial commitment period — verify terms before enrolling.

Is Found's semaglutide FDA-approved? Yes. Found now prescribes brand-name FDA-approved medications only — Wegovy, Zepbound, and oral Wegovy. They no longer offer compounded semaglutide following FDA enforcement actions in 2026.

How does Found compare to Ro? Found is more expensive than Ro (program fee on top of medication vs. Ro's flat $149/mo), but includes video consultations with obesity medicine specialists and behavioral coaching that Ro doesn't offer. Found is better for patients who want structured support. Ro is better for patients who want the lowest-cost branded GLP-1 access. For a detailed comparison of their clinical protocols and oversight differences, see our Ro vs Found GLP-1 protocol comparison.

Data Sources & Methodology

Pricing and protocol data sourced from Found's public website and verified via checkout flow, April 2026. Patient experience data drawn from public reviews (Google, Trustpilot, Reddit) and independent patient outreach. Telehealth Ally has no commercial relationship with this provider. Rankings and ratings are editorial-only.

Related Resources

• Found Provider Profile — Full medication lineup, pricing, and consultation details
• Found vs Calibrate Comparison — Which comprehensive program is right for you?
• Mochi Health vs. Found Comparison — How Found stacks up against Mochi's specialist model
• Found vs Henry Meds for GLP-1 — Found's clinical program vs Henry Meds' cash-pay model
• Best GLP-1 Weight Loss Programs 2026 — All major providers ranked
• GLP-1 Weight Regain Prevention Guide — Evidence-based maintenance strategies
• Switching Between GLP-1 Medications — How to transition between GLP-1 options
• GLP-1 Pricing Breakdown by Provider — Side-by-side cost comparison